Navigation Links
DrugRisk Update: Byetta Lawsuits Headed to Special Federal Court
Date:9/17/2013

New York, NY (PRWEB) September 17, 2013

The diabetes drug resource center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. A federal panel recently consolidated a growing number of lawsuits alleging the drug caused cancer to a multidistrict litigation court for expedited handling*.

DrugRisk seeks to improve patient safety by providing the latest recalls, safety alerts, research and litigation news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Byetta is a popular injectable medication prescribed to those with type-II diabetes to lower blood sugar levels. However, the resource center has added information showing experts disagree about its safety.

In 2011, a study from UCLA suggested subjects given Byetta may have higher occurrences of pancreatic cancer and thyroid cancer**. This year, the Journal for the American Medical Association also advised that drugs like Byetta can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

The Institute for Safe Medication Practices has attributed a majority of serious diabetes drug side effect reports to the FDA to Byetta****. However, the FDA has not issued a recall or required new warning labels.

Now, DrugRisk has learned that, due to the growing number of patients who have filed a Byetta lawsuit alleging cancer, the Judicial Panel on Multidistrict Litigation has consolidated cases to a special multidistrict litigation federal court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California)*.

Anyone affected by cancer after taking Byetta is encouraged to visit the DrugRisk center or speak with a lawyer about their legal options. However, DrugRisk only recommends lawyers who have already handled these complex Byetta lawsuits.

For more information on the research, side effects and litigation news related to Byetta and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*JPML 8/26/13; jpml.uscourts.gov/sites/jpml/files/MDL-2452-Initial_Transfer-07-13.pdf
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****ISMP QuarterWatch April, 2013.ismp.org/QuarterWatch/pdfs/2012Q3.pdf

Read the full story at http://www.prweb.com/releases/byetta-pancreatic-thyroid/cancer-symptoms/prweb11130048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
2. DrugRisk Update: Latest Court Order Moves Mirena Lawsuits Forward
3. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
4. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
5. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
6. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
7. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
8. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
9. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
10. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
11. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... companies, has achieved ISO 17100:2015 certification following a comprehensive audit performed by ... globally recognized standard that establishes guidance for critical processes within translation, quality ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, ... technology behind SmartCap, which was founded in 2008 to address the limitations of ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... 23, 2017 , ... Zachary Cattell, President of the Indiana ... industry expert at the 2017 Sector Summit hosted by Ivy Tech Community College ... Gerry Dick, will feature an employer and an association representative from five of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
(Date:1/23/2017)... January 23, 2017 Longer life expectancy and rising ... global market for medical device technologies. BCC Research reveals in ... Asia-Pacific region, should see strong growth due to rising ... incomes. Continue Reading ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: